MRI radiomics and nutritional-inflammatory biomarkers: a powerful combination for predicting progression-free survival in cervical cancer patients undergoing concurrent chemoradiotherapy

MRI radiomics and nutritional-inflammatory biomarkers: a powerful combination for predicting progression-free survival in cervical cancer patients undergoing concurrent chemoradiotherapy

Abstract Objective This study aims to develop and validate a predictive model that integrates clinical features, MRI radiomics, and nutritional-inflammatory biomarkers to forecast progression-free survival (PFS) in cervical cancer (CC) patients undergoing concurrent chemoradiotherapy (CCRT). The goa...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qi Yan, Menghan- Wu, Jing Zhang, Jiayang- Yang, Guannan- Lv, Baojun- Qu, Yanping- Zhang, Xia Yan, Jianbo- Song
Format:	Article
Language:	English
Published:	BMC 2024-10-01
Series:	Cancer Imaging
Subjects:	Cervical cancer Concurrent chemoradiotherapy MRI radiomics Nutritional-inflammatory biomarkers Prognosis
Online Access:	https://doi.org/10.1186/s40644-024-00789-2
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Longitudinal dynamic MRI radiomic models for early prediction of prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy
by: Chang Cai, et al.
Published: (2024-12-01)

Quality of life in patients with pan-cancer undergoing concurrent chemoradiotherapy: a bibliometric analysis (1995-2024)
by: Ao Shen, et al.
Published: (2025-08-01)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
by: Arunima Gupta, et al.
Published: (2014-01-01)

Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients
by: Jinbiao Xu, et al.
Published: (2025-05-01)

Delta-radiomics analysis based on magnetic resonance imaging to identify radiation proctitis in patients with cervical cancer after radiotherapy
by: Jing Xue, et al.
Published: (2025-01-01)

Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy for locally advanced cervical cancer: a multicenter real-world study
by: Jiwei Li, et al.
Published: (2025-05-01)

Development and validation of a prognostic nomogram incorporating neutrophil-to-albumin ratio for predicting overall survival in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy
by: Xin Hua, et al.
Published: (2025-01-01)

A novel radiomics model combining GTVp, GTVnd, and clinical data for chemoradiotherapy response prediction in patients with advanced NSCLC
by: Ya Li, et al.
Published: (2025-07-01)

Consolidation immunotherapy following concurrent chemoradiotherapy in a patient with sinonasal NUT carcinoma: a case report
by: Xiaotao Geng, et al.
Published: (2024-12-01)

A Phase II Clinical Trial of Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced High-Grade Thymic Tumors
by: Ning Xu, MD, et al.
Published: (2025-06-01)

Harnessing unsupervised machine learning with [18F]FDG PET/CT to develop a composite model for predicting overall survival in cervical cancer patients undergoing concurrent chemoradiotherapy
by: Jinyu Shi, et al.
Published: (2025-05-01)

Nomogram based on the advanced lung cancer inflammation index and other relevant clinical factors for patients with cervical squamous cell carcinoma undergoing concurrent chemoradiotherapy
by: Xiao-Chun Wang, et al.
Published: (2025-07-01)

Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial
by: Ke Zhang, et al.
Published: (2025-02-01)

Immunotherapy concurrently administered with chemoradiotherapy in limited-stage small-cell lung cancer
by: Liuhua Long, et al.
Published: (2025-07-01)

Comparison of oncological outcomes and complication rate between radical hysterectomy and concurrent chemoradiotherapy in stage IIICr cervical cancer without parametrial invasion
by: Hee Yeun Yoon, et al.
Published: (2025-04-01)

MRI-based radiomics for predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis
by: Zhongfan Liao, et al.
Published: (2025-03-01)

Tislelizumab and GP regimen neoadjuvant therapy followed by concurrent chemoradiotherapy with nimotuzumab in patients with stage IVA nasopharyngeal carcinoma: a retrospective study
by: Mingfen Lai, et al.
Published: (2025-06-01)

Comment on: Concurrent chemoradiotherapy versus radiotherapy alone in postoperative high-risk adenoid cystic carcinoma of the head and neck: A propensity score-matched analysis
by: Erkan Topkan, et al.
Published: (2025-07-01)

Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio
by: Jing Yu, et al.
Published: (2024-12-01)

Sequential therapy (triple drug-based induction chemotherapy followed by concurrent chemoradiotherapy) in locally advanced inoperable head and neck cancer patients - Single institute experience
by: Naresh Somani, et al.
Published: (2011-01-01)

Concurrent chemoradiotherapy with S-1 versus platinum in the treatment of locoregionally advanced nasopharyngeal carcinoma: a multicenter, retrospective, propensity score-matched analysis
by: Chenbin Bian, et al.
Published: (2024-11-01)

The clinical outcomes of induction chemotherapy followed by radiotherapy vs. chemoradiotherapy in locally advanced hypopharyngeal squamous cell carcinoma: A retrospective study
by: Ke Jiang, et al.
Published: (2024-10-01)

Baseline MRI habitat imaging for predicting treatment response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Muzhen He, et al.
Published: (2025-07-01)

A comparative analysis of survival outcomes and adverse effects between preoperative brachytherapy with radical surgery and concurrent chemoradiotherapy in patients with locally advanced cervical cancer
by: Yuna Niu, et al.
Published: (2025-02-01)

Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non‐small cell lung cancer
by: Xiaxia Chen, et al.
Published: (2024-09-01)

Effect of concurrent chemoradiation with cisplatin versus concurrent chemoradiation with carboplatin in locally advanced carcinoma cervix: A quasi-experimental study
by: Syed Md. Asadul Hoque, et al.
Published: (2025-05-01)

S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective study
by: Xin Wang, et al.
Published: (2024-12-01)

Ten-year survival outcomes of concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma in the IMRT era: A retrospective cohort study stratified by high- and low-risk profiles
by: Wang-Jian Li, et al.
Published: (2025-09-01)

Assessment of various risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting amongst patients receiving concurrent chemoradiotherapy: A prospective study
by: S. Navaneetha Krishnan, et al.
Published: (2025-01-01)

Associations between MRI radiomics analysis and tumor-micro milieu in uterine cervical cancer
by: Hans-Jonas Meyer, et al.
Published: (2025-07-01)

Single-cell RNA sequencing analysis reveals a lack of CXCL13+ T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy
by: Xia Li, et al.
Published: (2025-06-01)

CT radiomics identifying non‐responders to neoadjuvant chemoradiotherapy among patients with locally advanced rectal cancer
by: Zinan Zhang, et al.
Published: (2023-02-01)

Survival prediction in gliomas based on MRI radiomics combined with clinical factors and molecular biomarkers
by: Min Hao, et al.
Published: (2025-08-01)

Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy
by: Fiorella Di Pastena, et al.
Published: (2024-11-01)

Reliability of radiomic analysis on multiparametric MRI for patients affected by autosomal dominant polycystic kidney disease
by: Francesca Lussana, et al.
Published: (2025-05-01)

Development and validation of MRI-based radiomics model for clinical symptom stratification of extrinsic adenomyosis
by: Man Sun, et al.
Published: (2025-12-01)

MRI-Based Machine Learning and Radiomics Methods for Assessing Spinal Cord Function in Patients with Mild Cervical Spondylotic Myelopathy
by: He Wang, et al.
Published: (2025-06-01)

MRI IN THE ASSESSMENT OF TUMOR RESPONSE TO CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
by: N. G. Trukhacheva, et al.
Published: (2016-02-01)

MRI based radiomics nomogram for predict recurrence of non functioning pituitary macroadenomas post surgery
by: Ji-ping Zhao, et al.
Published: (2025-04-01)

DCE-MRI radiomics of primary breast lesions combined with ipsilateral axillary lymph nodes for predicting efficacy of NAT
by: Yiyao Sun, et al.
Published: (2025-04-01)